Cited by 187Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatments

TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia

Open access
Rohrer, J.D., Geser, F., Zhou, J., Gennatas, E.D., Sidhu, M., Trojanowski, J.Q., DeArmond, S.J., Miller, B.L. +1 more·2010·Neurology

Abstract

BACKGROUND: We sought to describe the antemortem clinical and neuroimaging features among patients with frontotemporal lobar degeneration with TDP-43 immunoreactive inclusions (FTLD-TDP). METHODS: Subjects were recruited from a consecutive series of patients with a primary neuropathologic diagnosis of FTLD-TDP and antemortem MRI. Twenty-eight patients met entry criteria: 9 with type 1, 5 with type 2, and 10 with type 3 FTLD-TDP. Four patients had too sparse FTLD-TDP pathology to be subtyped. Clinical, neuropsychological, and neuroimaging features of these cases were reviewed. Voxel-based morphometry was used to assess regional gray matter atrophy in relation to a group of 50 cognitively normal control subjects. RESULTS: Clinical diagnosis varied between the groups: semantic dementia was only associated with type 1 pathology, whereas progressive nonfluent aphasia and corticobasal syndrome were only associated with type 3. Behavioral variant frontotemporal dementia and frontotemporal dementia with motor neuron disease were seen in type 2 or type 3 pathology. The neuroimaging analysis revealed distinct patterns of atrophy between the pathologic subtypes: type 1 was associated with asymmetric anterior temporal lobe atrophy (either left- or right-predominant) with involvement also of the orbitofrontal lobes and insulae; type 2 with relatively symmetric atrophy of the medial temporal, medial prefrontal, and orbitofrontal-insular cortices; and type 3 with asymmetric atrophy (either left- or right-predominant) involving more dorsal areas including frontal, temporal, and inferior parietal cortices as well as striatum and thalamus. No significant atrophy was seen among patients with too sparse pathology to be subtyped. CONCLUSIONS: FTLD-TDP subtypes have distinct clinical and neuroimaging features, highlighting the relevance of FTLD-TDP subtyping to clinicopathologic correlation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318202038c

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TDP-43 pathological burden may further contribute toward the exclusive effects within FTD subjects.

    “Transactive response DNA binding protein 43 kDa (TDP‐43) pathological burden may further contribute toward the exclusive effects within FTD subjects, as type two TDP‐43 sub‐types have previously exhibited distinct atrophy patterns involving the mPFC. 62”

    From High vulnerability of medial prefrontal pyramidal neurons in post-stroke, vascular, Alzheimer's disease, and aging-related dementias (2026) · cites this paper as [62]

    The Results report that type 2 FTLD-TDP was associated with significant atrophy in the medial prefrontal cortex, and the Discussion describes distinct atrophy patterns across TDP-43 subtypes. The paper does not establish that pathological burden contributes to the citing study’s “exclusive effects” within FTD subjects. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Osterrieth PA. Le test de copie d'une figure complexe: con- tribution a l'eìtude de la perception et de la me ìmoire. Arch Psychol 1944;30:206 -256.
  2. Reitan RM. Validity of the Trailmaking Test as an indica- tion of organic brain damage. Percept Mot Skills 1958;8: 271-276.

Cited by

Sorted by citations

Authors
Rohrer, J. D., Geser, F., Zhou, J., Gennatas, E. D., Sidhu, M., Trojanowski, J. Q., DeArmond, S. J., Miller, B. L., & Seeley, W. W.
Affiliations
University of California, San Francisco (US)
Corresponding author
Seeley, W.W.
Venue
Neurology
Published
2010-12-14
Volume
75
Issue
24
Pages
2204-2211
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2002632820
Cited by
187
References
34
Citations by year
2026: 5 · 2025: 9 · 2024: 11 · 2023: 7 · 2022: 13 · 2021: 15 · 2020: 12 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 16 · 2014: 9 · 2013: 17 · 2012: 17
FWCI
10.69
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • Wellcome Trust
  • National Institutes of Health (5u01ag024904-10)
  • National Institute on Aging (P50-AG23501, RC1AG035427, P01 AG 17586-10, UO1AG029213-01, P30AG036468, 1 U01 AG 024904-05, P30AG010124, P01AG009215, P30 AG 10124-18, P01AG017586, AG17586, AG-10124, R01AG033017, 1P01 AG-19724-07, U01AG029213, AG023501, P01-AG19724, P01 AG 09215-20, P01AG019724, P50AG023501)
  • National Institute of Neurological Disorders and Stroke (P50NS053488, RC2NS069368)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
FTLD-TDP, frontotemporal lobar degeneration, semantic dementia, progressive nonfluent aphasia, corticobasal syndrome, behavioral variant frontotemporal dementia, clinicopathological correlation, voxel-based morphometry
MeSH terms
Aged, Aged, 80 and over, Aphasia, Atrophy, Brain, Inclusion Bodies, DNA-Binding Proteins, Female, Frontal Lobe, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Temporal Lobe, Thalamus, Frontotemporal Lobar Degeneration, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review